These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31378829)

  • 1. Non-peptidyl small molecule, adenosine, 5'-Se-methyl-5'-seleno-, 2',3'-diacetate, activates insulin receptor and attenuates hyperglycemia in type 2 diabetic Lepr
    Lan ZJ; Lei Z; Yiannikouris A; Yerramreddy TR; Li X; Kincaid H; Eastridge K; Gadberry H; Power C; Xiao R; Lei L; Seale O; Dawson K; Power R
    Cell Mol Life Sci; 2020 Apr; 77(8):1623-1643. PubMed ID: 31378829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of NPC43 counters hyperglycemia and activates insulin receptor in streptozotocin-induced type 1 diabetic mice.
    Lan ZJ; Lei Z; Nation L; Li X; Yiannikouris A; Yerramreddy TR; Kincaid H; Eastridge K; Xiao R; Goettl R; Power R
    BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32998869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally efficacious novel small molecule 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose selectively and potently stimulates insulin receptor and alleviates diabetes.
    Cao Y; Li Y; Kim J; Ren Y; Himmeldirk K; Liu Y; Qian Y; Liu F; Chen X
    J Mol Endocrinol; 2013; 51(1):15-26. PubMed ID: 23549408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mulberry (Morus alba L.) Fruit Extract Containing Anthocyanins Improves Glycemic Control and Insulin Sensitivity via Activation of AMP-Activated Protein Kinase in Diabetic C57BL/Ksj-db/db Mice.
    Choi KH; Lee HA; Park MH; Han JS
    J Med Food; 2016 Aug; 19(8):737-45. PubMed ID: 27441957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nardostachys jatamansi DC Extract Alleviates Insulin Resistance and Regulates Glucose Metabolism in C57BL/KsJ-db/db Mice Through the AMP-Activated Protein Kinase Signaling Pathway.
    You HN; Park MH; Hwang SY; Han JS
    J Med Food; 2018 Apr; 21(4):324-331. PubMed ID: 29630449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mulberry anthocyanin extract ameliorates insulin resistance by regulating PI3K/AKT pathway in HepG2 cells and db/db mice.
    Yan F; Dai G; Zheng X
    J Nutr Biochem; 2016 Oct; 36():68-80. PubMed ID: 27580020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Selective Protein Tyrosine Phosphatase Inhibitor, 2,2',3,3'-Tetrabromo-4,4',5,5'-tetrahydroxydiphenylmethane, Ameliorates Type 2 Diabetes Mellitus in BKS db Mice.
    Li C; Luo J; Guo S; Jia X; Guo C; Li X; Xu Q; Shi D
    Mol Pharm; 2019 May; 16(5):1839-1850. PubMed ID: 30974944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Lepr
    Samad MB; Mohsin MNAB; Razu BA; Hossain MT; Mahzabeen S; Unnoor N; Muna IA; Akhter F; Kabir AU; Hannan JMA
    BMC Complement Altern Med; 2017 Aug; 17(1):395. PubMed ID: 28793909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation.
    Ong KW; Hsu A; Tan BK
    Biochem Pharmacol; 2013 May; 85(9):1341-51. PubMed ID: 23416115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angelica gigas Ameliorates Hyperglycemia and Hepatic Steatosis in C57BL/KsJ-db/db Mice via Activation of AMP-Activated Protein Kinase Signaling Pathway.
    Bae UJ; Choi EK; Oh MR; Jung SJ; Park J; Jung TS; Park TS; Chae SW; Park BH
    Am J Chin Med; 2016; 44(8):1627-1638. PubMed ID: 27852130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
    Dong Y; Gao G; Fan H; Li S; Li X; Liu W
    PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity.
    Corbin JA; Bhaskar V; Goldfine ID; Bedinger DH; Lau A; Michelson K; Gross LM; Maddux BA; Kuan HF; Tran C; Lao L; Handa M; Watson SR; Narasimha AJ; Zhu S; Levy R; Webster L; Wijesuriya SD; Liu N; Wu X; Chemla-Vogel D; Lee SR; Wong S; Wilcock D; White ML
    PLoS One; 2014; 9(2):e88684. PubMed ID: 24533136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
    Tian F; Ying HM; Wang YY; Cheng BN; Chen J
    Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
    Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
    Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice.
    Xiong WT; Gu L; Wang C; Sun HX; Liu X
    J Ethnopharmacol; 2013 Dec; 150(3):935-45. PubMed ID: 24095831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
    Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
    J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes.
    Lin Y; Sun Z
    Br J Pharmacol; 2011 Feb; 162(3):597-610. PubMed ID: 20883475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice.
    Nagashima T; Shigematsu N; Maruki R; Urano Y; Tanaka H; Shimaya A; Shimokawa T; Shibasaki M
    Mol Pharmacol; 2010 Nov; 78(5):961-70. PubMed ID: 20736318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
    Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
    Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.